Guided Therapeutics, Inc. (GTHP)

OTCMKTS: GTHP · Delayed Price · USD
+0.110 (27.50%)
Sep 30, 2022 4:00 PM EDT - Market closed
Market Cap 18.70M
Revenue (ttm) 89,000
Net Income (ttm) -2.44M
Shares Out 36.66M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,751
Open 0.400
Previous Close 0.400
Day's Range 0.400 - 0.510
52-Week Range 0.300 - 0.780
Beta 0.68
Analysts n/a
Price Target n/a
Earnings Date n/a

About GTHP

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 199... [Read more...]

Industry Medical Devices
IPO Date Jul 1, 1997
CEO Gene Cartwright
Employees 5
Stock Exchange OTCMKTS
Ticker Symbol GTHP
Full Company Profile


There is no news available yet.